Avancerad sökning
Visar resultat 1 - 5 av 8 avhandlingar som matchar ovanstående sökkriterier.
1. The role of fibroblast growth factor-23 in chronic kidney disease-mineral and bone disorder
Sammanfattning : Fibroblast growth factor-23 (FGF23) was initially identified as the causative factor of autosomal dominant hypophosphatemic rickets. Further studies confirmed that FGF23 is predominantly expressed in the osteocytes and osteoblasts of bone and that circulating FGF23 acts on the kidney to inhibit renal phosphate reabsorption and 1,25(OH)2D3 hydroxylation. LÄS MER
2. Aortic valve replacement with stentless bioprostheses : prospective long-term studies of the Biocor and the Toronto SPV
Sammanfattning : Background: Aortic valve disease is increasing among the elderly and aortic valve replacement is the most common cardiac surgical valve procedure in adults. Aortic stenosis (AS) is often associated with left ventricular hypertrophy (LVH) in an unexplained pattern. LÄS MER
3. Childhood malignant disease and consequences for growth hormone secretion, intellectual function and cardiovascular risk
Sammanfattning : In childhood onset growth hormone deficiency (GHD) a reduction in cardiac left ventricular mass (LVMi) and impairment of cardiac systolic function, as well as in glomerular filtration rate (GFR) has been shown. In study I, we showed that a low dose of GH treatment for 10 months resulted in increased LVMi and kidney size. LÄS MER
4. Monitoring blood glucose and obesity in type 2 diabetes in primary care
Sammanfattning : Background: Type 2 diabetes is a common chronic disease worldwide. An important part of the treatment is monitoring and treating the elevated levels of blood glucose. But there is also a need for monitoringother risk factors that confer an increased risk for vascular complications. LÄS MER
5. Impact of chronic kidney disease on the cardiovascular system : studies in non-dialysis patients and healthy people
Sammanfattning : Background: Cardiac and arterial remodeling and stiffening occur in end-stage renal disease. The presence of cardiovascular (CV) alterations in earlier-stage chronic kidney disease (CKD) is less well studied. LÄS MER